DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Richardson PG, Larocca A, Lelu X. et al.
The burden of relapsed/refractory multiple myeloma: an indirect comparison of health-related quality of life burden across different types of advanced cancers at baseline and after treatment based on HORIZON (OP-106) study of melflufen plus dexamethasone.
Blood 2019;
134: 3487
DOI: 10.1182/blood-2019-124832.
Access:
We do not assume any responsibility for the contents of the web pages of other providers.